View in EDS HTML Full Text PDF Full Text

Outcomes of de novo belatacept‐based immunosuppression regimen and avoidance of calcineurin inhibitors in recipients of kidney allografts at higher risk for underutilization.

Saved in:

Bibliographic Details
Title:	Outcomes of de novo belatacept‐based immunosuppression regimen and avoidance of calcineurin inhibitors in recipients of kidney allografts at higher risk for underutilization.
Authors:	Patel, Ankita¹ (AUTHOR) ankita.patel@mountsinai.org, Shertel, Tara² (AUTHOR), Wynd, Michael² (AUTHOR), Wadhera, Vikram³ (AUTHOR), Serur, David¹ (AUTHOR), Schleich, Benjamin⁴ (AUTHOR), Yushkov, Yuriy³ (AUTHOR), Goldstein, Michael³ (AUTHOR)
Source:	Nephrology. Nov2022, Vol. 27 Issue 11, p901-905. 5p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	13205358
DOI:	10.1111/nep.14106